Back to results
US 2004/0167085 A1Published application
Pharmaceutical compositions comprising a hmg-coa reductase inhibitor
AssigneeSandoz Ltd.
InventorsDeepak Hedge, Sushrut Kulkarni
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition comprising as an active ingredient an HMG-CoA reductase inhibitor and an aminosugar.
Claims12
A pharmaceutical composition comprising as an active ingredient an HMG-CoA reductase inhibitor;
- characterised in that said composition comprises an aminosugar, with the proviso that compositions
- comprising dehydroeplandrosterone (DHEA), a desquamating agent selected from retinoids, acylated salicylic acid derivatives or HMG-CoA reductase Inhibitors, and sugar derivatives, and
- comprising germs for a koji-making raw material and monacolin K, are excluded.
A pharmaceutical composition consisting of
- a HMG-CoA reductase inhibitor as an active ingredient,
- an aminosugar, and
- pharmaceutically acceptable excipient selected from one or more filler and/or binder and/or disintegrant and/or lubricant.
A tablet for oral administration consisting of pravastatin In the form of a sodium salt, one or more filler, binder, disintegrant and/or lubricant, and aminosugar as a pH-adjusting (basifying) agent In such an amount, that a dispersion of said tablet In water has a pH of 7.0 to 8.7.
Dependencies are inferred from the claim text.